BlackRock Institutional Trust Company, N.A. - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 95 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$8,288,000
+17.9%
796,132
+2.5%
0.00%0.0%
Q3 2016$7,031,000
+21.3%
776,868
+0.2%
0.00%0.0%
Q2 2016$5,797,000
-16.4%
775,035
+0.7%
0.00%0.0%
Q1 2016$6,938,000
-3.6%
770,015
+38.2%
0.00%0.0%
Q4 2015$7,199,000
+36.4%
557,169
+2.0%
0.00%0.0%
Q3 2015$5,277,000
+209.3%
546,316
+229.5%
0.00%
Q2 2015$1,706,000
+108.3%
165,796
+124.8%
0.00%
Q1 2015$819,000
-5.6%
73,754
-1.1%
0.00%
Q4 2014$868,000
-47.0%
74,559
+0.7%
0.00%
Q3 2014$1,639,000
-28.5%
74,043
-10.3%
0.00%
Q2 2014$2,293,00082,5090.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$1,471,0001.42%
Orchard Capital Management, LLC 251,826$80,0000.03%
GSA CAPITAL PARTNERS LLP 486,568$154,0000.02%
Icon Wealth Advisors, LLC 400,132$1270.02%
ACADIAN ASSET MANAGEMENT LLC 7,483,053$2,365,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 2,042,816$646,0000.01%
WIPFLI FINANCIAL ADVISORS LLC, 200,000$63,0000.00%
WEALTH EFFECTS LLC 18,316$6,0000.00%
James J. Burns & Company, LLC 25,142$8,0000.00%
Bayesian Capital Management, LP 68,600$22,0000.00%
View complete list of AKEBIA THERAPEUTICS INC shareholders